Evaluating the Synthetic Drug Control Strategy PDF Download
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Evaluating the Synthetic Drug Control Strategy PDF full book. Access full book title Evaluating the Synthetic Drug Control Strategy by United States. Congress. House. Committee on Government Reform. Subcommittee on Criminal Justice, Drug Policy, and Human Resources. Download full books in PDF and EPUB format.
Author: United States. Congress. House. Committee on Government Reform. Subcommittee on Criminal Justice, Drug Policy, and Human Resources
Publisher:
ISBN:
Category : Medical
Languages : en
Pages : 248
Get Book Here
Book Description
Author: United States. Congress. House. Committee on Government Reform. Subcommittee on Criminal Justice, Drug Policy, and Human Resources
Publisher:
ISBN:
Category : Medical
Languages : en
Pages : 248
Get Book Here
Book Description
Author:
Publisher: DIANE Publishing
ISBN: 9781422321058
Category :
Languages : en
Pages : 258
Get Book Here
Book Description
Author: United Nations Office on Drugs and Crime
Publisher:
ISBN: 9789210041744
Category :
Languages : en
Pages : 0
Get Book Here
Book Description
The 2019 World Drug Report will include an updated overview of recent trends on production, trafficking and consumption of key illicit drugs. The Report contains a global overview of the baseline data and estimates on drug demand and supply and provides the reference point for information on the drug situation worldwide.
Author: Bryce Pardo
Publisher:
ISBN: 9781977403384
Category : Medical
Languages : en
Pages : 0
Get Book Here
Book Description
Deaths involving synthetic opioids, such as fentanyl, increased from roughly 3,000 in 2013 to more than 30,000 in 2018. This book provides readers with insights intended to improve their understanding of the synthetic opioid problem.
Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
ISBN: 0309459575
Category : Medical
Languages : en
Pages : 483
Get Book Here
Book Description
Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.
Author: United States. Congress. House. Committee on Government Operations. Legislation and National Security Subcommittee
Publisher:
ISBN:
Category : Drug abuse
Languages : en
Pages :
Get Book Here
Book Description
Author: Institute of Medicine
Publisher: National Academies Press
ISBN: 0309175380
Category : Medical
Languages : en
Pages : 329
Get Book Here
Book Description
Drug abuse persists as one of the most costly and contentious problems on the nation's agenda. Pathways of Addiction meets the need for a clear and thoughtful national research agenda that will yield the greatest benefit from today's limited resources. The committee makes its recommendations within the public health framework and incorporates diverse fields of inquiry and a range of policy positions. It examines both the demand and supply aspects of drug abuse. Pathways of Addiction offers a fact-filled, highly readable examination of drug abuse issues in the United States, describing findings and outlining research needs in the areas of behavioral and neurobiological foundations of drug abuse. The book covers the epidemiology and etiology of drug abuse and discusses several of its most troubling health and social consequences, including HIV, violence, and harm to children. Pathways of Addiction looks at the efficacy of different prevention interventions and the many advances that have been made in treatment research in the past 20 years. The book also examines drug treatment in the criminal justice setting and the effectiveness of drug treatment under managed care. The committee advocates systematic study of the laws by which the nation attempts to control drug use and identifies the research questions most germane to public policy. Pathways of Addiction provides a strategic outline for wise investment of the nation's research resources in drug abuse. This comprehensive and accessible volume will have widespread relevanceâ€"to policymakers, researchers, research administrators, foundation decisionmakers, healthcare professionals, faculty and students, and concerned individuals.
Author: Paul I. Dargan
Publisher: Academic Press
ISBN: 0128190302
Category : Medical
Languages : en
Pages : 556
Get Book Here
Book Description
Novel Psychoactive Substances: Classification, Pharmacology and Toxicology, Second Edition provides readers with a comprehensive examination on the classification, detection, supply and availability of novel psychoactive substances, otherwise known as "legal highs." The book covers individual classes of novel psychoactive substances that have recently emerged onto the recreational drug scene and provides an overview of the pharmacology of the substance and a discussion of their associated acute and chronic harm and toxicity. This second edition addresses drugs new to the scene, with completely updated and revised chapters. Written by international experts in the field, this multi-authored book is an essential reference for scientists, clinicians, academics, and regulatory and law enforcement professionals. - Includes chapters written by international experts in the field - Presents a comprehensive overview on the classification, detection, availability and supply of novel psychoactive substances, in addition to the pharmacology and toxicology associated with the substance - Offers a single source for all interested parties working in this area, including scientists, academics, clinicians, law enforcement and regulatory agencies - Provides a full treatment of novel psychoactive substances that have recently emerged onto the recreational drug scene, including amphetamines and the synthetic cannabinoid receptors in 'spice' and 'K2'
Author: Julia Buxton
Publisher: Emerald Group Publishing
ISBN: 183982882X
Category : Social Science
Languages : en
Pages : 353
Get Book Here
Book Description
The ebook edition of this title is Open Access and freely available to read online. Examining the impact of drug criminalisation on a previously overlooked demographic, this book argues that women are disproportionately affected by a flawed policy approach.
Author: Albert N. Stanhous
Publisher:
ISBN: 9781606925454
Category : Drug abuse
Languages : en
Pages : 282
Get Book Here
Book Description
The President's National Drug Control Strategy describes the Administration's strategic approach for reducing illicit drug use in the United States. The Administration's Synthetic Drug Control Strategy is a companion to the National Strategy. It follows the main principles set out in the National Strategy: that supply and demand are the ultimate drivers in all illicit drug markets and that a balanced approach incorporating prevention, treatment, and market disruption initiatives (such as interdiction, arrests, prosecutions, and regulatory interventions) is the best way to reduce the supply of, and demand for, illicit drugs. The Synthetics Strategy also adheres to the format of the National Strategy by setting ambitious goals for reducing synthetic drug use at a rate approximating 5 percent each year. Specifically, the Synthetics Strategy outlines a strategy for reducing past month methamphetamine use by 15 percent over three years and past month prescription drug abuse2 by 15 percent over three years. Additionally, because the production of methamphetamine poses significant human and environmental risks, the Administration has also set a goal of reducing domestic methamphetamine Labouratories by 25 percent over three years. This and past administrations have traditionally avoided promulgating drug control strategies focused on a single drug or a single category of drugs. However, the unique nature of illicit markets for synthetic drugs warrants a targeted response, partly because those markets contain unique challenges and vulnerabilities. Unlike marijuana or cocaine, for example, either the final synthetic drug (as with prescription drugs) or its ingredients (as with methamphetamine) are designed for legal possession and use. Other reasons include the extreme health and environmental problems associated with the production of drugs such as methampheamine and the indisputably destructive nature of methamphetamine use itself. The Synthetics Strategy adheres to the following outline. Following this introduction, it describes the state of the illicit markets for methamphetamine and controlled substance prescription drugs, including progress made over the last several years. It then sets targets for reduced numbers in three principal categories: illicit methamphetamine use, domestic methamphetamine Labouratories, and the illicit use of controlled substance prescription drugs. This portion explains the fundamental principles and insights guiding the Synthetics Strategy and describes how performance goals will be measured. Next, the document describes the strategy itself, explaining how, given the current state of the illicit synthetic drug market, the Administration will meet targets for use and production by the end of 2008. Here, both supply reduction and demand reduction activities are addressed for both methamphetamine use and controlled substance prescription drug abuse. Finally, the end of the document addresses the problem of responding to the aftermath of methamphetamine production. Improving our knowledge about the health and environmental consequences of methamphetamine labs is critically important toward improving the safety and security of Americans, including the children who are found in or near toxic Labouratories.
